Original Article

Serum and Synovial Fluid Levels of Interleukin-17A in Primary Knee Osteoarthritis Patients: Correlations With Functional Status, Pain, and Disease Severity

Volume 37 · Issue 2 Publish Date: June 30, 2022
Full Text PDF HTML
DOI
Shereen KAMEL ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Minia University, Minia, Egypt image/svg+xml
Rehab KHALAF ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Minia University, Minia, Egypt image/svg+xml
Hend MONESS ORCID
Department of Clinical Pathology, Faculty of Medicine, Minia University, Minia, Egypt image/svg+xml
Shimaa AHMED ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Minia University, Minia, Egypt image/svg+xml
Shereen KAMEL, Rehab KHALAF, Hend MONESS, & Shimaa AHMED. (2022). Serum and Synovial Fluid Levels of Interleukin-17A in Primary Knee Osteoarthritis Patients: Correlations With Functional Status, Pain, and Disease Severity. Archives of Rheumatology, 37(2), 187–194. https://doi.org/10.46497/ArchRheumatol.2022.7931
Full Text PDF HTML

Abstract

Objectives: This study aims to assess the serum and synovial fluid (SF) levels of interleukin (IL)-17A in primary knee osteoarthritis (KOA) patients and to study their correlations with functional status, pain, and disease severity.

Patients and methods: This cross-sectional study was conducted between December 2017 and March 2018 and it included 70 patients (46 males, 24 females; mean age 57.3±10.0 years; range 34 to 76 years) with primary KOA and 30 age-, sex-, and body mass index-matched healthy individuals (20 males, 10 females; mean age 53.3±10.3 years; range, 35 to 70 years). Western Ontario and McMaster Universities osteoarthritis index (WOMAC), visual analog scale (VAS), Lequesne index, and Kellgren and Lawrence (KL) grading scale were used for assessment of the disease. IL-17A levels were measured in the serum for patients and healthy controls, and in SF for patients only using an enzyme-linked immunosorbent assay.

Results: Serum levels of IL-17A were significantly higher in KOA patients than controls (p=0.04). A positive correlation was found between serum and SF IL-17A levels. Serum and SF IL-17A levels had positive correlations with VAS, WOMAC pain score, Lequesne pain score, WOMAC function score, and Lequesne index. SF IL-17A levels had strong positive correlations with radiographic severity (KL grade) and duration of OA.

Conclusion: Higher IL-17A levels in primary KOA patients were significantly associated with longer disease duration, higher pain scores, worse quality of life, extreme disability, and advanced structural damage. Therapeutics that target IL-17A warrant further investigation.

Similar Articles

Article Info
Published In
Journal Archives of Rheumatology
Volume / Issue Volume 37 · Issue 2
Pages 187-194
History
Published Online June 30, 2022
License
Affiliations
Shereen KAMEL ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Minia University, Minia, Egypt
Rehab KHALAF ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Minia University, Minia, Egypt
Hend MONESS ORCID
Department of Clinical Pathology, Faculty of Medicine, Minia University, Minia, Egypt
Shimaa AHMED ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Minia University, Minia, Egypt
Cite this Article
Shereen KAMEL, Rehab KHALAF, Hend MONESS, & Shimaa AHMED. (2022). Serum and Synovial Fluid Levels of Interleukin-17A in Primary Knee Osteoarthritis Patients: Correlations With Functional Status, Pain, and Disease Severity. Archives of Rheumatology, 37(2), 187–194. https://doi.org/10.46497/ArchRheumatol.2022.7931
Share
Outlines